[{"address1": "301 - 1665 Ellis Street", "city": "Kelowna", "state": "BC", "zip": "V1Y 2B3", "country": "Canada", "phone": "833-811-8797", "website": "https://www.tryptherapeutics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. James S. Kuo M.B.A., M.D.", "age": 58, "title": "Co-Founder & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 19728, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Molloy ASIP, B.A., C.F.A.", "age": 50, "title": "Chief Business Officer & Director", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 135821, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason  Carroll", "title": "CEO & Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James P. Gilligan MSIB, Ph.D.", "age": 71, "title": "President & Chief Scientific Officer", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 233680, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William James Garner M.D., M.P.H., MPH", "age": 57, "title": "Founder & MD", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 41747, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  O'Neill", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sidney  Taubenfeld R.Ph", "title": "Chief Operating Officer", "fiscalYear": 2023, "totalPay": 36032, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joy  Willis", "title": "Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael H. Silverman B.Sc., F.A.C.P., FACR, M.B.A., M.D.", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1949, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0259, "open": 0.0249, "dayLow": 0.015, "dayHigh": 0.0249, "regularMarketPreviousClose": 0.0259, "regularMarketOpen": 0.0249, "regularMarketDayLow": 0.015, "regularMarketDayHigh": 0.0249, "beta": -1.116, "volume": 222500, "regularMarketVolume": 222500, "averageVolume": 53466, "averageVolume10days": 42611, "averageDailyVolume10Day": 42611, "marketCap": 1880176, "fiftyTwoWeekLow": 0.0041, "fiftyTwoWeekHigh": 0.0919, "fiftyDayAverage": 0.0271626, "twoHundredDayAverage": 0.04417065, "currency": "USD", "enterpriseValue": 4828854, "floatShares": 51335589, "sharesOutstanding": 96419296, "heldPercentInsiders": 0.4096, "bookValue": -0.052, "lastFiscalYearEnd": 1693440000, "nextFiscalYearEnd": 1725062400, "mostRecentQuarter": 1701302400, "netIncomeToCommon": -4793340, "trailingEps": -0.06, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "TRYPF", "underlyingSymbol": "TRYPF", "shortName": "TRYP THERAPEUTICS INC", "longName": "Tryp Therapeutics Inc.", "firstTradeDateEpochUtc": 1612794600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "9cb12462-7365-35fe-9d45-06c6b7e87d95", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0195, "recommendationKey": "none", "totalCash": 2064213, "totalCashPerShare": 0.021, "totalDebt": 5012890, "quickRatio": 0.303, "currentRatio": 0.313, "returnOnAssets": -1.4038299, "freeCashflow": -1802319, "operatingCashflow": -3620152, "financialCurrency": "CAD", "trailingPegRatio": null}]